Accession PRJCA013411
Title Transcriptomic analyses of non-small cell lung cancer during targeted therapy
Relevance Medical
Data types Whole genome sequencing
Transcriptome or Gene expression
Raw sequence reads
Single cell sequencing
Organisms Homo sapiens
Description Targeted therapy has improved the treatment non-small cell lung cancer (NSCLC) with driver gene mutations. However, most patients will develop drug resistance after therapy. Here, we combined bulk, single cell and spatial transcriptomics to identify the spatial landscape of the NSCLC tumor microenvironment (TME) during targeted therapy. Multidimensional bioinformatics analyses revealed distinct transcriptomic heterogeneity of the TME. Our study provides novel insights into the complex ecosystem of NSCLC and offers clues for combinational therapies to overcome drug resistance.
Sample scope Multiisolate
Release date 2023-07-09
Publication
PubMed ID Article title Journal name DOI Year
37537219 Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II study Nature Communications 10.1038/s41467-023-40349-z 2023
Grants
Agency program Grant ID Grant title
No funding support
Submitter Peng Zhang (zhangpeng1121@tongji.edu.cn)
Organization Shanghai Pulmonary Hospital Tongji University
Submission date 2022-11-22

Project Data

Resource name Description
BioSample (111)  show -